M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, USA.
Int J Parasitol Drugs Drug Resist. 2022 Dec;20:76-88. doi: 10.1016/j.ijpddr.2022.10.005. Epub 2022 Oct 26.
Anthelmintic resistance is reported in equine nematodes with increasing frequency in recent years, and no new anthelmintic classes have been introduced during the past 40 years. This manuscript reviews published literature describing anthelmintic resistance in cyathostomins, Parascaris spp., and Oxyuris equi with special emphasis on larvicidal efficacy against encysted cyathostomin larvae and strongylid egg reappearance periods (ERP). Resistance to benzimidazoles and pyrimidines is highly prevalent in cyathostomin populations around the world, and macrocyclic lactone resistance has been documented in cyathostomins in recent years as well. Two recent studies have documented resistance to the larvicidal regimen of fenbendazole, whereas the larvicidal efficacy of moxidectin is variable, but with no evidence of a reduction from historic levels. In the 1990s, ERP estimates were 8-10 and 12-16 weeks for ivermectin and moxidectin, respectively, while several studies published after year 2000 found ERPs to be 5 weeks for both compounds. This is a clear change in anthelmintic performance, but it remains unclear if this is due to development of anthelmintic resistance or selection for other biological traits leading to a quicker resumption of strongylid egg shedding following anthelmintic treatment. Macrocyclic lactone resistance is common in Parascaris spp. around the world, but recent reports suggests that resistance to the two other classes should be monitored as well. Finally, O. equi has been reported resistant to ivermectin and moxidectin in countries representing four continents. In conclusion, multi-drug resistance is becoming the norm in managed cyathostomin populations around the world, and a similar pattern may be emerging in Parascaris spp. More work is required to understand the mechanisms behind the shortened ERPs, and researchers and veterinarians around the world are encouraged to routinely monitor anthelmintic efficacy against equine nematodes.
近年来,马属动物线虫的驱虫药耐药性报告日益增多,在过去 40 年中没有引入新的驱虫药类别。本文综述了已发表的文献,描述了马胃蝇蛆、副蛔虫和马蛔虫的驱虫药耐药性,特别强调了针对囊尾蚴幼虫的杀幼虫效果和强烈线虫卵再出现期(ERP)。在世界各地的胃蝇蛆种群中,苯并咪唑类和嘧啶类药物的耐药性非常普遍,近年来也有报道称胃蝇蛆对大环内酯类药物有耐药性。最近的两项研究记录了对芬苯达唑杀幼虫方案的耐药性,而莫昔克丁的杀幼虫效果则不同,但没有证据表明其效果比历史水平有所降低。在 20 世纪 90 年代,伊维菌素和莫昔克丁的 ERP 估计值分别为 8-10 周和 12-16 周,而 2000 年后发表的几项研究发现,这两种化合物的 ERP 为 5 周。这是驱虫药性能的明显变化,但尚不清楚这是由于驱虫药耐药性的发展还是由于选择了其他生物学特性,导致在驱虫药治疗后,强烈线虫卵的重新出现更快。副蛔虫在世界各地都普遍存在对大环内酯类药物的耐药性,但最近的报告表明,也应该监测对其他两类药物的耐药性。最后,O. equi 已在代表四大洲的国家报告对伊维菌素和莫昔克丁有耐药性。总之,多药耐药性正在成为世界各地管理的胃蝇蛆种群的常态,副蛔虫可能也出现了类似的模式。需要进一步的工作来了解 ERP 缩短的机制,鼓励世界各地的研究人员和兽医定期监测抗马属线虫的驱虫药效果。